Search Result "Janus kinase 2 (JAK2) inhibitors"
QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 15 Issue: 2 Year: 2018 Page: 169-180
Author(s): Basheerulla Shaik,Satya P. Gupta,Tabassum Zafar,K. Anita
Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 7 Year: 2014 Page: 638-651
Author(s): Marcin Mielecki,MaÅgorzata Milner-Krawczyk,Krystyna Grzelak,Damian Mielecki,Krystiana A. Krzysko,Bogdan Lesyng,Waldemar Priebe
Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 306-312
Author(s): Kunihiro Yamaoka, Yoshiya Tanaka
Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2017 Page: 268-294
Author(s): Eleni Vrontaki,Georgia Melagraki,Antreas Afantitis,Thomas Mavromoustakos,George Kollias
Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 18 Year: 2019 Page: 1531-1543
Author(s): Jun Dai,LiXi Yang,Glynn Addison
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 546-555
Author(s): Nilda L. Alicea-Velazquez, Titus J. Boggon
The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4551-4558
Author(s): R. Baskin, A. Majumder, P. P. Sayeski
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1767-1784
Author(s): M. Cetkovic-Cvrlje, H. E. Tibbles